<DOC>
	<DOCNO>NCT01265706</DOCNO>
	<brief_summary>This study perform observe incidence major cardiovascular event Korean patient AMI give pitavastatin 2mg 4mg longer 1 year .</brief_summary>
	<brief_title>Livalo Acute Myocardial Infarction Study ( LAMIS )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Patients STEMI , NSTEMI Patients satisfy least one follow 1 . Patients LDLC ≥ 130 mg/dL 2 . Patients LDLC ≥ 100 mg/dL regard require cholesterol lower therapy investigator 3 . Patients take statin require continuous cholesterol lower therapy Patients satisfy least two following 1 . The change Ischemic ECG 2 . CK , CKMB , TroponinI increase two time 3 . The symptom ACS 1 . Patients instent restenosis PCI coronary artery bypass 2 . Patients cardiogenic shock 3 . Patients severe heart failure ( Left ventricular ejection fraction le 30 % ) 4 . Patients take cyclosporine 5 . Patients experienced hypersensitivity pitavastatin 6 . Patients dialysis treatment 7 . Patients participate clinical trial 8 . Patients stop take concomitant drug 9 . Pregnant lactate woman suspect pregnancy 10 . Patients regard ineligible study investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors</keyword>
</DOC>